Patents by Inventor Jessica Flechtner

Jessica Flechtner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
    Patent number: 10653771
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
    Type: Grant
    Filed: January 3, 2018
    Date of Patent: May 19, 2020
    Assignee: GENOCEA BIOSCIENCES, INC.
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne, George R. Siber
  • Antigen screening system
    Patent number: 10570387
    Abstract: Methods and compositions for identifying antigens of human lymphocytes are provided herein.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: February 25, 2020
    Assignee: GENOCEA BIOSCIENCES, INC.
    Inventors: Jessica Flechtner, Todd Gierahn
  • VACCINES AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE
    Publication number: 20180369365
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
    Type: Application
    Filed: January 3, 2018
    Publication date: December 27, 2018
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne, George R. Siber
  • ANTIGEN SCREENING SYSTEM
    Publication number: 20180362966
    Abstract: Methods and compositions for identifying antigens of human lymphocytes are provided herein.
    Type: Application
    Filed: December 19, 2017
    Publication date: December 20, 2018
    Inventors: Jessica Flechtner, Todd Gierahn
  • Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
    Patent number: 9895436
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
    Type: Grant
    Filed: November 12, 2013
    Date of Patent: February 20, 2018
    Assignee: Genocea Biosciences, Inc.
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne, George R. Siber
  • Antigen screening system
    Patent number: 9873870
    Abstract: Methods and compositions for identifying antigens of human lymphocytes are provided herein.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: January 23, 2018
    Assignee: Genocea Biosciences, Inc.
    Inventors: Jessica Flechtner, Todd Gierahn
  • Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
    Patent number: 9782474
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. Highly effective vaccines and immunogenic compositions against HSV-2, which can be used therapeutically or prophylactically, are described.
    Type: Grant
    Filed: November 23, 2011
    Date of Patent: October 10, 2017
    Assignee: Genocea Biosciences, Inc.
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne
  • Fused antigen vaccines and compositions against
    Patent number: 9765125
    Abstract: Streptococcus pneumoniae is a major health concern, especially in very young, elderly, or immunocompromised patients. The present disclosure provides, inter alia, certain highly effective vaccines and pharmaceutical compositions in Streptococcus pneumoniae that contain fusion proteins. The antigens may be used therapeutically or prophylactically.
    Type: Grant
    Filed: January 18, 2013
    Date of Patent: September 19, 2017
    Assignees: Genocea Biosciences, Inc., Children's Medical Center Corporation
    Inventors: Jessica Flechtner, Richard Malley
  • Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
    Patent number: 9624273
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. Highly effective vaccines and immunogenic compositions against HSV-2 which can be used therapeutically or prophylactically, are described.
    Type: Grant
    Filed: November 21, 2012
    Date of Patent: April 18, 2017
    Assignee: Genocea Biosciences, Inc.
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne
  • ANTIGEN SCREENING SYSTEM
    Publication number: 20160083717
    Abstract: Methods and compositions for identifying antigens of human lymphocytes are provided herein.
    Type: Application
    Filed: April 30, 2015
    Publication date: March 24, 2016
    Inventors: Jessica Flechtner, Todd Gierahn
  • Antigen screening system
    Patent number: 9045791
    Abstract: Methods and compositions for identifying antigens of human lymphocytes are provided herein.
    Type: Grant
    Filed: September 26, 2012
    Date of Patent: June 2, 2015
    Assignee: Genocea Biosciences, Inc.
    Inventors: Jessica Flechtner, Todd Gierahn
  • FUSED ANTIGEN VACCINES AND COMPOSITIONS AGAINST STREPTOCOCCUS PNEUMONIAE
    Publication number: 20150056239
    Abstract: Streptococcus pneumoniae is a major health concern, especially in very young, elderly, or immunocompromised patients. The present disclosure provides, inter alia, certain highly effective vaccines and pharmaceutical compositions in Streptococcus pneumoniae that contain fusion proteins. The antigens may be used therapeutically or prophylactically.
    Type: Application
    Filed: January 18, 2013
    Publication date: February 26, 2015
    Inventors: Jessica Flechtner, Richard Malley
  • NUCLEIC ACID VACCINES AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE
    Publication number: 20140328870
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
    Type: Application
    Filed: November 21, 2012
    Publication date: November 6, 2014
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne
  • VACCINES AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE
    Publication number: 20140227307
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
    Type: Application
    Filed: November 12, 2013
    Publication date: August 14, 2014
    Applicant: GENOCEA BIOSCIENCES, INC.
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne, George R. Siber
  • Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
    Patent number: 8617564
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
    Type: Grant
    Filed: May 24, 2010
    Date of Patent: December 31, 2013
    Assignee: Genocea Biosciences, Inc.
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne, George R. Siber
  • VACCINES AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE
    Publication number: 20130337000
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
    Type: Application
    Filed: November 23, 2011
    Publication date: December 19, 2013
    Applicant: GENOCEA BIOSCIENCES, INC.
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne
  • Antigen screening system
    Patent number: 8313894
    Abstract: Methods and compositions for identifying antigens of human lymphocytes are provided herein.
    Type: Grant
    Filed: July 1, 2009
    Date of Patent: November 20, 2012
    Assignee: Genocea Biosciences, Inc.
    Inventors: Jessica Flechtner, Todd Gierahn
  • CHLAMYDIA ANTIGENS AND USES THEREOF
    Publication number: 20110293664
    Abstract: Disclosed are novel chlamydia antigens, nucleic acids encoding the antigens, and immunogenic compositions including the antigens. Methods of using the antigens to elicit immune responses (e.g., T cell-mediated and/or B cell-mediated immune responses) comprising administering an immunogenic composition including one or more of the novel antigens may be used for prophylaxis and/or treatment of chlamydia-mediated diseases.
    Type: Application
    Filed: December 17, 2009
    Publication date: December 1, 2011
    Applicant: GENOCEA BIOSCIENCES, INC.
    Inventors: Kenya Cohane, Michele Picard, Todd Gierahn, Jessica Flechtner
  • VACCINES AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE
    Publication number: 20100330112
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
    Type: Application
    Filed: May 24, 2010
    Publication date: December 30, 2010
    Applicant: Genocea Biosciences, Inc.
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne
  • ANTIGEN SCREENING SYSTEM
    Publication number: 20100048418
    Abstract: Methods and compositions for identifying antigens of human lymphocytes are provided herein.
    Type: Application
    Filed: July 1, 2009
    Publication date: February 25, 2010
    Inventors: Jessica Flechtner, Todd Gierahn